Brad Blaser, MD, PHD
College of Medicine
Bradley Blaser, MD, PhD, is a member of the Leukemia Research Program at the OSUCCC – James, where he seeks to identify factors in the hematopoietic niche that promote the development of myeloid neoplasia.
His current research involves using samples from the OSUCCC Leukemia Tissue Bank to find candidate genes that will be screened for effects on blood stem cells in the zebrafish system using genetic gain- and loss-of-function approaches. Cell biological and molecular mechanisms are then studied down to the single cell level using time-lapse video microscopy, flow cytometry and next-generation sequencing techniques to identify factors that may be useful in improving hematopoietic reconstitution in patients undergoing hematopoietic stem cell transplantation.
Dr. Blaser has co-authored many articles in scientific journals such as Blood, Leukemia Research and the Journal of Immunology and has presented his findings to the American Society of Hematology and the International Congress of Immunology.
MD, The Ohio State University
Columbus, OH (USA)